Last reviewed · How we verify
NCT04285528
Sedation and Analgesia Using PFK Versus General Anesthesia in Urological Procedures
NA trial testing General anesthetia Fentanyl and Propofol in Anesthesia in 200 participants. Completed in 1 February 2020.
1 December 2019
Quick facts
| Lead sponsor | University of Jordan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 17 April 2019 |
| Primary completion | 1 December 2019 |
| Estimated completion | 1 February 2020 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- General anesthetia Fentanyl and Propofol — full drug profile →
- PFK
Conditions studied
- Anesthesia — all drugs for Anesthesia →
- Urologic Diseases — all drugs for Urologic Diseases →
Sponsor
University of Jordan
Who can join
18 and older, any sex, with Anesthesia or Urologic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anesthesia in urological surgeries might constitute a great challenge to anesthesiologists. Especially that a great proportion of these patients are elderly with a lot of comorbidities. This put these patients at the risk of developing medical adverse events after being anesthetized by general anesthesia. The aim of this study is to compare between intravenous sedation with analgesia versus general anesthesia in patients undergoing urological surgical procedures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04285528
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anesthesia
Currently open trials in the same condition.
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
- NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting
Other University of Jordan trials
Trials by the same sponsor.
- NCT07370545 — Impact of Presentation Sequence on Patient Tooth Shade Selection · NA · completed
- NCT07279285 — Sweet-Tasting Solution Versus Placebo to Reduce Pain During Local Anesthetic Injection in Children · NA · not yet recruiting
- NCT07310485 — Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa · NA · enrolling by invitation
- NCT06977009 — Influence of Occlusal Reduction on Endodontic Postoperative Pain · NA · recruiting
- NCT07212413 — Effect of Snow-plow Technique on the Postoperative Pain Following Direct Composite Restoration · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04285528 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jordan
- Last refreshed: 3 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04285528.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing